AAPL   384.12 (+0.72%)
MSFT   214.07 (+0.58%)
FB   243.38 (-0.08%)
GOOGL   1,524.34 (+1.38%)
AMZN   3,119.51 (+1.25%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
MU   49.68 (-0.06%)
GE   6.68 (-2.62%)
TSLA   1,383.18 (+1.27%)
AMD   55.27 (+3.44%)
ACB   11.71 (-3.70%)
GILD   75.30 (-0.41%)
NFLX   505.94 (+0.63%)
BA   176.55 (-1.96%)
AAPL   384.12 (+0.72%)
MSFT   214.07 (+0.58%)
FB   243.38 (-0.08%)
GOOGL   1,524.34 (+1.38%)
AMZN   3,119.51 (+1.25%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
MU   49.68 (-0.06%)
GE   6.68 (-2.62%)
TSLA   1,383.18 (+1.27%)
AMD   55.27 (+3.44%)
ACB   11.71 (-3.70%)
GILD   75.30 (-0.41%)
NFLX   505.94 (+0.63%)
BA   176.55 (-1.96%)
AAPL   384.12 (+0.72%)
MSFT   214.07 (+0.58%)
FB   243.38 (-0.08%)
GOOGL   1,524.34 (+1.38%)
AMZN   3,119.51 (+1.25%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
MU   49.68 (-0.06%)
GE   6.68 (-2.62%)
TSLA   1,383.18 (+1.27%)
AMD   55.27 (+3.44%)
ACB   11.71 (-3.70%)
GILD   75.30 (-0.41%)
NFLX   505.94 (+0.63%)
BA   176.55 (-1.96%)
AAPL   384.12 (+0.72%)
MSFT   214.07 (+0.58%)
FB   243.38 (-0.08%)
GOOGL   1,524.34 (+1.38%)
AMZN   3,119.51 (+1.25%)
NVDA   416.97 (+2.04%)
CGC   16.03 (-1.84%)
MU   49.68 (-0.06%)
GE   6.68 (-2.62%)
TSLA   1,383.18 (+1.27%)
AMD   55.27 (+3.44%)
ACB   11.71 (-3.70%)
GILD   75.30 (-0.41%)
NFLX   505.94 (+0.63%)
BA   176.55 (-1.96%)
Log in

NASDAQ:NERVMinerva Neurosciences News Headlines

$3.66
+0.01 (+0.27 %)
(As of 07/9/2020 10:26 AM ET)
Add
Compare
Today's Range
$3.58
Now: $3.66
$3.69
50-Day Range
$3.40
MA: $5.70
$14.70
52-Week Range
$1.81
Now: $3.66
$15.22
Volume5,397 shs
Average Volume1.94 million shs
Market Capitalization$143.55 million
P/E RatioN/A
Dividend YieldN/A
Beta1.58

Headlines

Minerva Neurosciences (NASDAQ NERV) News Headlines

Source:
DateHeadline
Minerva Neurosciences Inc (NASDAQ:NERV) Sees Large Increase in Short InterestMinerva Neurosciences Inc (NASDAQ:NERV) Sees Large Increase in Short Interest
www.americanbankingnews.com - July 5 at 7:38 PM
Minerva Neurosciences (NASDAQ:NERV) Receives Buy Rating from HC WainwrightMinerva Neurosciences (NASDAQ:NERV) Receives Buy Rating from HC Wainwright
www.americanbankingnews.com - July 3 at 8:29 AM
Minerva Neurosciences (NERV) "Buy" Rating Reaffirmed at JMP SecuritiesMinerva Neurosciences' (NERV) "Buy" Rating Reaffirmed at JMP Securities
www.americanbankingnews.com - July 3 at 7:50 AM
Minerva Neurosciences (NASDAQ:NERV) Given "Hold" Rating at William BlairMinerva Neurosciences (NASDAQ:NERV) Given "Hold" Rating at William Blair
www.americanbankingnews.com - July 2 at 3:58 PM
BRIEF-Minerva Neurosciences Exercises Right To Opt Out Of Agreement With Janssen For SeltorexantBRIEF-Minerva Neurosciences Exercises Right To Opt Out Of Agreement With Janssen For Seltorexant
www.reuters.com - July 2 at 12:42 AM
Minerva Neurosciences, Inc: Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)Minerva Neurosciences, Inc: Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)
www.finanznachrichten.de - July 1 at 9:40 AM
Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)Minerva Neurosciences Exercises Right to Opt Out of Agreement With Janssen for Seltorexant (MIN-202)
finance.yahoo.com - July 1 at 9:40 AM
Zacks: Analysts Expect Minerva Neurosciences Inc (NASDAQ:NERV) to Post -$0.37 EPSZacks: Analysts Expect Minerva Neurosciences Inc (NASDAQ:NERV) to Post -$0.37 EPS
www.americanbankingnews.com - July 1 at 3:42 AM
Minerva Neurosciences Inc (NASDAQ:NERV) Given Consensus Recommendation of "Buy" by AnalystsMinerva Neurosciences Inc (NASDAQ:NERV) Given Consensus Recommendation of "Buy" by Analysts
www.americanbankingnews.com - June 26 at 6:14 AM
Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Dont?Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?
www.nasdaq.com - June 22 at 2:27 PM
Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?Do Options Traders Know Something About Minerva Neurosciences (NERV) Stock We Don't?
finance.yahoo.com - June 22 at 9:27 AM
NERV Minerva Neurosciences, Inc Common StockNERV Minerva Neurosciences, Inc Common Stock
www.nasdaq.com - June 21 at 6:23 PM
Short Interest in Minerva Neurosciences Inc (NASDAQ:NERV) Grows By 20.2%Short Interest in Minerva Neurosciences Inc (NASDAQ:NERV) Grows By 20.2%
www.americanbankingnews.com - June 19 at 2:49 PM
Global Insomnia Medication Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026Global Insomnia Medication Market2020Production, Revenue, Price and Gross Margin Analysis with Forecasts to 2026
www.marketwatch.com - June 7 at 2:33 PM
Minerva Neurosciences (NERV) Looks Good: Stock Adds 8.4% in SessionMinerva Neurosciences (NERV) Looks Good: Stock Adds 8.4% in Session
finance.yahoo.com - June 5 at 2:40 PM
How Minerva Neurosciences (NERV) Stock Stands Out in a Strong IndustryHow Minerva Neurosciences (NERV) Stock Stands Out in a Strong Industry
finance.yahoo.com - June 2 at 1:45 PM
Why Minerva Neurosciences Is Heading Higher TodayWhy Minerva Neurosciences Is Heading Higher Today
finance.yahoo.com - June 1 at 2:28 PM
REVISED WEBCAST & CALL INFORMATION: Minerva Neurosciences to Hold Webcast and Call With Key Opinion Leaders to Present Additional Analyses From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in SchizophreniaREVISED WEBCAST & CALL INFORMATION: Minerva Neurosciences to Hold Webcast and Call With Key Opinion Leaders to Present Additional Analyses From Phase 3 Trial of Roluperidone (MIN-101) for Treatment of Negative Symptoms in Schizophrenia
finance.yahoo.com - June 1 at 9:27 AM
Minerva Shares Tank 72% As Schizophrenia Drug Misses Trial GoalsMinerva Shares Tank 72% As Schizophrenia Drug Misses Trial Goals
finance.yahoo.com - May 31 at 8:02 AM
BRIEF-Minerva Neurosciences Announces Results From Phase 3 Trial Of Roluperidone (Min-101) For Treatment Of Negative Symptoms In SchizophreniaBRIEF-Minerva Neurosciences Announces Results From Phase 3 Trial Of Roluperidone (Min-101) For Treatment Of Negative Symptoms In Schizophrenia
www.reuters.com - May 29 at 11:26 PM
Heres Why Minerva Neurosciences Collapsed TodayHere's Why Minerva Neurosciences Collapsed Today
finance.yahoo.com - May 29 at 6:21 PM
Minerva Neurosciences schizophrenia drug misses main goal in studyMinerva Neurosciences' schizophrenia drug misses main goal in study
www.reuters.com - May 29 at 1:20 PM
Minerva Schizophrenia-Drug Trial Misses Key EndpointsMinerva Schizophrenia-Drug Trial Misses Key Endpoints
finance.yahoo.com - May 29 at 1:20 PM
Notable Tuesday Option Activity: NERV, TSLA, FBNotable Tuesday Option Activity: NERV, TSLA, FB
www.nasdaq.com - May 26 at 7:05 PM
Edited Transcript of NERV earnings conference call or presentation 4-May-20 12:30pm GMTEdited Transcript of NERV earnings conference call or presentation 4-May-20 12:30pm GMT
finance.yahoo.com - May 25 at 6:46 PM
Momentum investing with Minerva Neurosciences Inc (NMQ:NERV)Momentum investing with Minerva Neurosciences Inc (NMQ:NERV)
uk.finance.yahoo.com - May 22 at 11:46 AM
Thinking about trading stocks or options in Moderna, Carnival Corp, Minerva Neurosciences, Apple, or Nvidia?Thinking about trading stocks or options in Moderna, Carnival Corp, Minerva Neurosciences, Apple, or Nvidia?
www.prnewswire.com - May 14 at 12:43 PM
Top Ranked Momentum Stocks to Buy for May 11thTop Ranked Momentum Stocks to Buy for May 11th
finance.yahoo.com - May 11 at 3:28 PM
BRIEF-Minerva Neurosciences Reports First Quarter 2020 Financial ResultsBRIEF-Minerva Neurosciences Reports First Quarter 2020 Financial Results
www.reuters.com - May 4 at 9:12 PM
Minerva Neurosciences Inc (NERV) Q1 2020 Earnings Call TranscriptMinerva Neurosciences Inc (NERV) Q1 2020 Earnings Call Transcript
finance.yahoo.com - May 4 at 9:12 PM
Minerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q1 2020 Results - Earnings Call TranscriptMinerva Neurosciences, Inc. (NERV) CEO Remy Luthringer on Q1 2020 Results - Earnings Call Transcript
seekingalpha.com - May 4 at 4:11 PM
Minerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business UpdatesMinerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business Updates
www.finanznachrichten.de - May 4 at 8:49 AM
Minerva Neurosciences Reports First Quarter 2020 Financial Results and Business UpdatesMinerva Neurosciences Reports First Quarter 2020 Financial Results and Business Updates
finance.yahoo.com - May 4 at 8:49 AM
Minerva Neurosciences to Report First Quarter 2020 Financial Results and Business Updates on May 4, 2020Minerva Neurosciences to Report First Quarter 2020 Financial Results and Business Updates on May 4, 2020
finance.yahoo.com - April 27 at 11:25 AM
Minerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business UpdatesMinerva Neurosciences, Inc: Minerva Neurosciences Reports First Quarter 2019 Financial Results and Business Updates
www.bloomberg.com - April 22 at 9:04 AM
Minerva Neurosciences, Inc: Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of RoluperidoneMinerva Neurosciences, Inc: Minerva Neurosciences Announces Completion of Patient Enrollment in Phase 3 Trial of Roluperidone
www.bloomberg.com - April 21 at 1:02 PM
Minerva Neurosciences, Inc. (NASDAQ:NERV): What Does Its Beta Value Mean For Your Portfolio?Minerva Neurosciences, Inc. (NASDAQ:NERV): What Does Its Beta Value Mean For Your Portfolio?
finance.yahoo.com - April 20 at 3:12 PM
Edited Transcript of NERV earnings conference call or presentation 9-Mar-20 12:30pm GMTEdited Transcript of NERV earnings conference call or presentation 9-Mar-20 12:30pm GMT
finance.yahoo.com - March 27 at 8:02 AM
MINERVA NEUROSCIENCES TO HOST KEY OPINION LEADER MEETING ON ROLUPERIDONE: A POTENTIALLY NOVEL MECHANISM TO TREAT THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIAMINERVA NEUROSCIENCES TO HOST KEY OPINION LEADER MEETING ON ROLUPERIDONE: A POTENTIALLY NOVEL MECHANISM TO TREAT THE NEGATIVE SYMPTOMS OF SCHIZOPHRENIA
finance.yahoo.com - March 24 at 12:08 PM
Are Options Traders Betting on a Big Move in Minerva Neurosciences (NERV) Stock?Are Options Traders Betting on a Big Move in Minerva Neurosciences (NERV) Stock?
finance.yahoo.com - March 19 at 1:12 PM
MINERVA NEUROSCIENCES UPDATES MARKET ON SHARE PRICE DROP AND TRADING HALTMINERVA NEUROSCIENCES UPDATES MARKET ON SHARE PRICE DROP AND TRADING HALT
finance.yahoo.com - March 12 at 7:44 PM
Minerva Neurosciences Inc (NERV) Q4 2019 Earnings Call TranscriptMinerva Neurosciences Inc (NERV) Q4 2019 Earnings Call Transcript
www.nasdaq.com - March 9 at 5:53 PM
BRIEF-Minerva Neurosciences Posts Q4 loss per share of $0.77BRIEF-Minerva Neurosciences Posts Q4 loss per share of $0.77
www.reuters.com - March 9 at 12:53 PM
Minerva Neurosciences EPS misses by $0.39Minerva Neurosciences EPS misses by $0.39
seekingalpha.com - March 9 at 7:52 AM
Minerva Neurosciences, Inc. to Host Earnings CallMinerva Neurosciences, Inc. to Host Earnings Call
finance.yahoo.com - March 9 at 7:52 AM
Minerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business UpdatesMinerva Neurosciences Reports Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates
finance.yahoo.com - March 9 at 7:52 AM
Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020Minerva Neurosciences to Report Fiscal 2019 Fourth Quarter and Year End Financial Results and Business Updates on March 9, 2020
finance.yahoo.com - March 2 at 9:07 AM
Minerva Neurosciences to Host Key Opinion Leader Meeting on Avolition, the Most Central Domain for the Successful Treatment of Negative Symptoms in SchizophreniaMinerva Neurosciences to Host Key Opinion Leader Meeting on Avolition, the Most Central Domain for the Successful Treatment of Negative Symptoms in Schizophrenia
finance.yahoo.com - February 28 at 3:06 PM
Who Has Been Buying Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares?Who Has Been Buying Minerva Neurosciences, Inc. (NASDAQ:NERV) Shares?
finance.yahoo.com - February 17 at 2:39 PM
Minerva Neurosciences, Inc.: Minerva Neurosciences Names Richard Russell PresidentMinerva Neurosciences, Inc.: Minerva Neurosciences Names Richard Russell President
www.bloomberg.com - February 14 at 7:55 PM
This page was last updated on 7/9/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.